Axogen, Inc. — Director's Dealing 2011

Oct 11, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AxoGen, Inc. (LECT)
CIK: 0000805928
Period of Report: 2011-09-30

Reporting Person: De Novo Ventures II, L.P. (10% Owner)
Reporting Person: De Novo Management II, L.L.C. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1426392	Indirect

Footnotes

F1: Pursuant to an Agreement and Plan of Merger, dated as of May 31, 2011, by and among LecTec Corporation ("LecTec"), Nerve Merger Sub Corp., a subsidiary of LecTec ("Merger Sub"), and AxoGen Corporation ("AC"), which the parties amended on June 30, 2011 and August 9, 2011 (as amended, the "Merger Agreement"), Merger Sub merged with and into AC, with AC continuing after the merger as the surviving corporation and a wholly owned subsidiary of LecTec (the "Merger"). The Merger was completed on September 30, 2011, and LecTec was renamed AxoGen, Inc. ("AxoGen"). In connection with the Merger, each share of AC common stock converted into 0.03727336 shares of LecTec common stock at the effective time of the Merger.

F2: The Shares are owned by De Novo Ventures II, L.P. ("De Novo"). De Novo Management II, LLC ("De Novo Management") is the sole general partner of De Novo.